David DeLuca
Overview
Explore the profile of David DeLuca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hilberink L, Wehage P, Pashai Fakhri M, Gaedcke S, DeLuca D, Mattis P, et al.
Pneumologie
. 2025 Feb;
79(3):229-235.
PMID: 39961349
Auscultation is one of the key medical skills in physical examination. The main problem with auscultation is the lack of objectivity of the findings and great dependence on the experience...
2.
Gauthier L, Ravi R, DeLuca D, Zhou W
Stroke
. 2024 Feb;
55(3):696-704.
PMID: 38406850
Background: Dose response has remained a priority area in motor rehabilitation research for decades, prompting several large randomized trials and meta-analyses. These between-subjects comparisons have revealed equivocal relationships between the...
3.
Schutz K, Pallenberg S, Kontsendorn J, DeLuca D, Sukdolak C, Minso R, et al.
Front Pharmacol
. 2023 Jul;
14:1171544.
PMID: 37469865
Triple-combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy with elexacaftor/tezacaftor/ivacaftor (ETI) was introduced in August 2020 in Germany for people with CF (pwCF) ≥12 years (yrs.) of age and...
4.
Jirmo A, Grychtol R, Gaedcke S, Liu B, DeStefano S, Happle C, et al.
Front Immunol
. 2023 May;
14:1127485.
PMID: 37251386
A single population of interferon-regulatory factor 8 (Irf8)-dependent conventional dendritic cell (cDC type1) is considered to be responsible for both immunogenic and tolerogenic responses depending on the surrounding cytokine ....
5.
Greer M, Liu B, Magnusson J, Fuehner T, Schmidt B, DeLuca D, et al.
J Heart Lung Transplant
. 2023 Apr;
42(2):209-217.
PMID: 37071121
Background: Chronic lung allograft dysfunction (CLAD) is a leading cause of graft loss in lung transplantation. Despite this, convincing treatment data is lacking, and protocols vary widely between centers. CLAD...
6.
Sivaraman K, Wrenger S, Liu B, Schaudien D, Hesse C, Gomez-Mariano G, et al.
J Leukoc Biol
. 2023 Feb;
113(1):58-70.
PMID: 36822165
Rodent models of lipopolysaccharide (LPS)-induced pulmonary inflammation are used for anti-inflammatory drug testing. We aimed to characterize mice responses to aerosolized LPS alone or with intraperitoneal (i.p.) delivery of alpha1-antitrypsin...
7.
Grychtol R, Riemann L, Gaedcke S, Liu B, DeLuca D, Forster R, et al.
J Allergy Clin Immunol
. 2023 Feb;
151(6):1525-1535.e4.
PMID: 36804993
Background: The Asthma Severity Scoring System (ASSESS) quantifies asthma severity in adolescents and adults. Scale performance in children younger than 12 years is unknown. Objective: To validate the ASSESS score...
8.
Albrecht M, Halle O, Gaedcke S, Pallenberg S, Camargo Neumann J, Witt M, et al.
Clin Transl Immunology
. 2022 Jun;
11(6):e1398.
PMID: 35757569
Objectives: The contribution of adaptive innate lymphocytes to IL-17A and IL-22 secretion at the end stage of chronic lung diseases remains largely unexplored. In order to uncover tissue- and disease-specific...
9.
Habener A, Grychtol R, Gaedcke S, DeLuca D, Dittrich A, Happle C, et al.
Eur Respir J
. 2022 May;
60(5).
PMID: 35595320
Background: Comprehensive studies investigated the role of T-cells in asthma which led to personalised treatment options targeting severe eosinophilic asthma. However, little is known about the contribution of B-cells to...
10.
Husing A, Wulfmeyer V, Gaedcke S, Fleig S, Rong S, DeLuca D, et al.
J Am Soc Nephrol
. 2022 May;
33(8):1487-1500.
PMID: 35537780
Background: The risk of cardiovascular events rises after AKI. Leukocytes promote atherosclerotic plaque growth and instability. We established a model of enhanced remote atherosclerosis after renal ischemia-reperfusion (IR) injury and...